A Yale-led team of researchers developed a new approach to scanning the brain for changes in synapses that are associated with common brain disorders. The technique may provide insights into the diagnosis and treatment of a broad range of disorders, including epilepsy, Alzheimer’s disease, schizophrenia, depression and Parkinson’s disease. Certain changes in synapses – the junctions between nerve cells in the brain – have been linked with brain disorders. But researchers have only been able to evaluate synaptic changes during autopsies. For their study, the research team set out to develop a method for measuring the number of synapses, or synaptic density, in the living brain. To quantify synapses throughout the brain, professor of radiology and biomedical imaging Richard Carson and his co-authors combined PET scanning technology with biochemistry. They developed a radioactive tracer that, when injected into the body, binds with a key protein that is present in all synapses across the brain. They observed the tracer through PET imaging and then applied mathematical tools to quantify synaptic density. The researchers used the imaging technique in both baboons and humans. They confirmed that the new method did serve as a marker for synaptic density. It also revealed synaptic loss in three patients with epilepsy compared to healthy individuals. ‘This is the first time we have synaptic density measurement in live human beings,’ said Carson, who is senior author on the study. ‘Up to now any measurement of synaptic density was post-mortem.’ The finding has several potential applications. With this non-invasive method, researchers may be able to follow the progression of many brain disorders, including epilepsy and Alzheimer’s disease, by measuring changes in synaptic density over time. Another application may be in assessing how pharmaceuticals slow the loss of neurons. ‘This opens the door to follow the natural evolution of synaptic density with normal aging and follow how drugs can alter synapses or synapse formation.’
Yale University http://tinyurl.com/hnrz9y8
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:42Scientists apply new imaging tool to common brain disorders
University of Missouri College of Engineering Dean and Bioengineering Professor Elizabeth Loboa and a team of colleagues recently discovered a way to slow and, in some cases, prevent the spread of MRSA while also regenerating new bone.
Methicillin resistant Staphylococcus aureus, or MRSA, infections are a critical problem in the medical world, including the area of regenerative medicine. This form of antibiotic-resistant staph infection can cause serious complications after typical invasive procedures and can be easily spread through skin-to-skin contact. MRSA is one of the foremost causes of osteomyelitis, a disease that inflames and destroys bone as well as surrounding soft tissue.
But University of Missouri College of Engineering Dean and Bioengineering Professor Elizabeth Loboa and a team of colleagues – Mahsa Mohiti-Asli and Casey Molina of the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University, Diteepeng Thamonwan of Silpakorn University in Thailand and Behnam Pourdeyhimi of NCSU – recently discovered a way to slow and, in some cases, prevent the spread of MRSA while also regenerating new bone.
Loboa and her colleagues discovered that by seeding the proper amount of silver into a biodegradable scaffold alongside bone-forming stem cells, they could still rapidly form bone while either inhibiting MRSA growth or killing the infection outright.
‘The silver ions go in and completely disrupt the MRSA cell machinery, and they can inhibit growth and kill the bacteria,’ Loboa said. ‘It’s a fine line. If you overuse too much of the silver, it’s bad for the mammalian cells. We want to make sure we don’t hurt our host cells but kill the bacterial cells.’
The threads of the bone-creating scaffold were coated with a silver ion-containing solution before testing. Silver has proven effective in undoing bacteria mechanically, making it harder for bacteria to develop immunity.
University of Missouri College of Engineering engineering.missouri.edu/2017/01/silver-ions-prove-effective-treating-killing-antibiotic-resistant-staph-infection/
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:41Silver ions prove effective in preventing, killing MRSA while forming bone
In the operating room of the future, robots will be an integral part of the surgical team, working alongside human surgeons to make surgeries safer, faster and more precise. Engineers in Michael Yip’s lab at UC San Diego are developing advanced robotic systems to help make that vision a reality.
From intelligent algorithms that can enable robots to lend a helping hand during surgery, to ‘smart’ endoscopes that can autonomously maneuver through sensitive nooks and crannies inside the body, the robotics technologies in Yip’s lab are all inspired by a common goal: to augment the capabilities of surgeons.
The goal is not to replace human surgeons, but to better assist and enable them to do much more, said Yip, a professor of electrical engineering. Human surgeons, he explained, are still needed to make decisions that can’t be left to a robot, such as what treatment is best for the patient, or how a surgical procedure should be performed.
Meanwhile, robots will be used to perform tasks that humans cannot. For example, flexible and dexterous robots armed with high-power computing and sub-millimeter precision will be able to perform minimally invasive surgery, control complex instruments and navigate through spaces in the body that a human surgeon can’t access. These robots could perform other advanced tasks, such as creating real-time 3D maps inside the body as they self-navigate, relying on a patient’s medical data and imaging information.
This vision illustrates the idea of ‘Shared Autonomy,’ the theme of the most recent UC San Diego Contextual Robotics Institute Forum held on campus during October. In an age of increasing automation, researchers in the institute, such as Yip, are focused on developing robotic systems that can interact well in a human world and benefit society.
The da Vinci Surgical System is a robotic surgical system designed to perform minimally invasive surgery. The system, developed by the company Intuitive Surgical, is remotely controlled by a surgeon from a console. The system is equipped with four robotic arms, but a surgeon is able to control only two of them at a time. Yip’s ARCLab currently has a full da Vinci Surgical System dedicated for research in shared autonomy.
Yip’s team aims to put the other two arms to work. To do this, they are creating software and hardware that will enable these arms to function autonomously. A goal is to have these robotic arms assist the primary surgeon with routine surgical tasks (suction, irrigation or pulling tissue back) that are tedious and are currently performed by additional human surgeons.
‘This would reduce the number of surgeons in the operating room, which would reduce the overall cost of the surgery,’ said Nikhil Das, an electrical engineering Ph.D. student in Yip’s lab. It would also free up surgeons who normally do these tasks to see other patients, he added.
Das develops motion planning algorithms that will enable the auxiliary arms to move without hitting obstacles, such as the surgeon-controlled manipulator arms. He is working on this project with undergraduate student Naman Gupta, who is visiting from Birla Institute of Technology and Science in Pilani, India. Gupta implements these algorithms in a simulated da Vinci system’s robotic arm and is in the process of validating his approach before moving it onto the ARCLab’s da Vinci system.
Other students in the ARCLab are incorporating haptics into the system so that surgeons operating the robotic arms can recover the textures and sensations of feeling the tissues, a critical sensation missing in current systems.
‘We’re trying to close the gap between the surgeon and the robot,’ Das said.
To reach truly small scales, the ARCLab is developing its own robotic catheters. These catheters are meter-long, millimeter-diameter flexible robots that can access the deepest parts of the body from atraumatic locations such as the leg. With 8 wires that are individually controlled by 8 different motors, Yip’s lab can shape and steer the robot catheters in more complex configurations and navigate far more effectively than surgeons could do manually.
One goal is to automate the catheter and incorporate haptic controls so that the operator can receive feedback from the motors. ‘That’s what makes our catheter different from the steerable catheters in industry,’ said Aaron Gunn, a mechanical engineering undergraduate working on this project.
University of California San Diego ucsdnews.ucsd.edu/feature/engineers_developing_advanced_robotic_systems_that_will_become_surgeons
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:41Engineers developing advanced robotic systems that will become surgeon’s right hand
Neurosurgeons want the quickest, most accurate information to help them make decisions during brain tumour surgery. A new method could accelerate that process.
Neurosurgeons and pathologists at Michigan Medicine are the first to execute stimulated Raman histology (SRH), a method that improves speed and diagnostic efficiency, in an operating room.
The researchers imaged tissue from 101 neurosurgical patients using conventional methods and the new method. Both techniques produced accurate results, they found, but the new method was much faster.
SRH, if applied widely, could change the pace and structure of an operation.
‘By achieving excellent image quality in fresh tissues, we’re able to make a diagnosis during surgery,’ says first author Daniel A. Orringer, M.D., assistant professor of neurosurgery at the University of Michigan Medical School. ‘This eliminates the lengthy process of sending tissues out of the OR for processing and interpretation.’
Today’s workflow for determining a diagnosis during an operation requires the surgeon wait 30 to 40 minutes while tissue is sent to a pathology lab for processing, sectioning, staining, mounting and interpretation. The entire team in the operating room may be idle while waiting for pathology results, Orringer says.
‘Our technique may disrupt the intraoperative diagnosis process in a great way, reducing it from a 30-minute process to about three minutes,’ Orringer says. ‘Initially, we developed this technology as a means of helping surgeons detect microscopic tumour, but we found the technology was capable of much more than guiding surgery.’
Stimulated Raman scattering microscopy, the technology behind SRH, was developed in 2008, but the hazardous lasers involved made it unsuitable for use in an operating room. A clinical version has now been developed and tested in the operating room for more than a year at U-M, with the fibre-laser-based microscope mounted onto a clinical cart that plugs into the wall.
To interpret the samples, researchers developed SRH, which creates images similar to those currently in use.
SRH uses virtual colouring to highlight the cellular and architectural features of brain tumours, with a result resembling traditional staining. The pathologist is then able to differentiate the tumour tissue from normal brain as usual.
‘It’s very similar to what we currently do in our intraoperative diagnosis, with the exception that the tissue is fresh, has not been processed or stained,’ says senior author Sandra Camelo-Piragua, M.D., assistant professor of pathology at U-M.
In the Nature Biomedical Engineering study, neuropathologists were given 30 specimen samples processed by SRH or traditional methods. They were told the same information about each patient’s medical history and the location of the tumour and asked to make a diagnosis.
Those pathologists, the U-M researchers found, were equally likely to make a correct diagnosis, whether they used SRH or conventional slides.
‘SRH imaging will ensure that appropriate and good-quality tissue is collected to reach our ultimate goal: accurate diagnosis,’ Camelo-Piragua says.
University of Michigan labblog.uofmhealth.org/health-tech/new-technique-slashes-diagnosis-time-during-brain-surgery
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:41New technique slashes diagnosis time during brain surgery
Michigan Medicine researchers employ novel technology to monitor vulnerabilities for cardiovascular events, aid in diagnosis and treatment Strokes and heart attacks often strike without warning. But, a unique application of a medical camera could one day help physicians know who is at risk for a cardiovascular event by providing a better view of potential problem areas.
‘The camera actually goes inside the vessels,’ says first author Luis Savastano, M.D., a Michigan Medicine resident neurosurgeon. ‘We can see with very high resolution the surface of the vessels and any lesions, such as a ruptured plaque, that could cause a stroke. This technology could possibly find the smoking gun’ lesion in patients with strokes of unknown cause, and may even be able to show which silent, but at-risk, plaques may cause a cardiovascular event in the future.’
The scanning fibre endoscope, or SFE, used in the study was invented and developed by co-author and University of Washington mechanical engineering research professor Eric Seibel, Ph.D.. He originally designed it for early cancer detection by clearly imaging cancer cells that are currently invisible with clinical endoscopes.
The Michigan Medicine team used the instrument for a new application: acquiring high-quality images of possible stroke-causing regions of the carotid artery that may not be detected with conventional radiological techniques.
Researchers generated images of human arteries using the SFE, which illuminates tissues with multiple laser beams, and digitally reconstructs high-definition images to determine the severity of atherosclerosis and other qualities of the vessel wall.
A unique application of a medical camera could one day help physicians know who is at risk for a cardiovascular event by providing a better view of potential problem areas.
‘In addition to discovering the cause of the stroke, the endoscope can also assist neurosurgeons with therapeutic interventions by guiding stent placement, releasing drugs and biomaterials and helping with surgeries,’ Seibel says.
In addition, the SFE uses fluorescence indicators to show key biological features associated with increased risk of stroke and heart attacks in the future.
‘The ability to identify and monitor the biological markers that render a plaque unstable and at risk for rupture could enable the detection of individuals within high-risk populations who are most likely to suffer from cardiovascular events, and therefore benefit the most from preventive treatment during the asymptomatic stage,’ says B. Gregory Thompson, M.D., professor of neurosurgery at the University of Michigan Medical School and a senior author on the new paper.
University of Michigan www.uofmhealth.org/news/archive/201702/laser-based-camera-improves-view-carotid-artery
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:40Laser-based camera improves view of the carotid artery
A new study from Karolinska Institutet shows that short-course preoperative radiotherapy combined with delayed surgery reduces the adverse side-effects of rectal cancer surgery without compromising its efficacy.
Rectal cancer affects some 2,000 men and women in Sweden every year. Preoperative radiotherapy was gradually introduced in the early 1990s, with a consequent improvement in prognosis for people with rectal cancer and reduction in the risk of local recurrence.
‘Back then we showed that preoperative radiotherapy reduces the risk of local recurrence by over 50 per cent for patients with rectal cancer,’ says principal investigator Anna Martling, senior consultant surgeon and professor at Karolinska Institutet’s Department of Molecular Medicine and Surgery. ‘Thanks to our results, radiotherapy is recommended to many rectal cancer patients.’ However, radiotherapy can cause adverse reactions and the optimal radiotherapeutic method and the interval between it and the ensuing surgery have been mooted.
The study is based on the claim that the adverse effects of rectal cancer treatment can be reduced by administering more but lower doses of radiation for a longer time, or by increasing the interval between radiotherapy and surgery. These hypotheses have now been tested in a study in which rectal cancer patients were randomly assigned to three different treatment arms:
Standard therapy, i.e. short-course (5×5 Gy) radiotherapy with direct surgery within a week.
Delayed surgery with short-course (5×5 Gy) radiotherapy followed by surgery after 4-8 weeks.
Delayed surgery with long-course (25×2 Gy) radiotherapy followed by surgery after 4-8 weeks.
The results of the study show that patients with delayed surgery develop fewer complications with equally good oncological outcomes. It also showed that there is no difference between long-course and short-course radiotherapy other than that the former considerably lengthens the time for treatment. Improved therapeutic strategies ‘The results of the study will give rise to improved therapeutic strategies, fewer complications with a sustained low incidence of local recurrence, and better survival rates for rectal cancer patients,’ says Professor Martling. ‘The results can now be immediately put to clinical use to the considerable benefit of the patients.’
Karolinska Institute ki.se/en/news/new-method-reduces-adverse-effects-of-rectal-cancer-treatment
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:40New method reduces adverse effects of rectal cancer treatment
Important steps in planning tumour surgery include identifying borders between tumour and healthy tissue and assessing the tumour stiffness, e.g. hard and calcified or soft and pliant. For decades, tumours near the surface of the body have been evaluated for stiffness by simple palpation-the physician pressing on the tissue. Because tumours within the skull cannot be palpated, researchers used Magnetic Resonance Elastography (MRE) to assess pituitary tumour stiffness by measuring waves transmitted through the skull into pituitary macroadenomas (PMAs). MRE reliably identified tumours that were soft enough for removal with a minimally-invasive suction technique versus harder tumours requiring more invasive surgery. ‘The group developed brain MRE several years ago and is now successfully applying it to clinical diagnosis and treatment,’ explained Guoying Liu, Ph.D., Director of the NIBIB Program in Magnetic Resonance Imaging. ‘This development of a new imaging technique followed by its practical application in surgical planning for better patient outcomes is an outstanding example of one of the main objectives of NIBIB-funded research.’ MRE is a special magnetic resonance imaging technique that captures snapshots of shear waves that move through the tissue and create elastograms-images that show tissue stiffness. John Huston III, M.D., Professor of Radiology at the Mayo Clinic in Rochester, MN, and senior author of the study, explains how MRE works. ‘MRE is similar to a drop of water hitting a still pond to create the ripples that move out in all directions. We generate tiny, harmless ripples, or shear waves, that travel through the brain of the patient. Our instruments measure how the ripples change as they move through the brain and those changes give us an extremely accurate measure–and a coloUr-coded picture–of the stiffness of the tissue.’ Ninety percent of PMAs are soft-nearly the consistency of toothpaste. Therefore, without MRE, surgeons would routinely plan for a procedure called transphenoidal resection that employs very thin instruments that are threaded through the nasal cavity to the pituitary gland at the base of the skull, where suction is used to remove the tumour. However, in about 10percent of the cases, the surgeon will encounter a hard tumour. At that point an attempt is made to break-up the tumour-essentially chipping away at it with sharp instruments. If that is not successful, the surgeon must perform a fully-invasive craniotomy that involves removing a piece of the skull bone in order to fully expose the tumour. The more extensive procedure means added risk and discomfort for patients, and up to a week-long recovery in the hospital compared to the transphenoidal approach that allows patients to leave the hospital in a day or two. Using MRE, hard PMAs can be identified and the more extensive craniotomy can be planned before starting the surgery, which makes the more invasive procedure less taxing for both the surgeon and patient. Similarly, MRE showing a soft PMA gives surgeons confidence that the nasal entry and removal by suction will be successful-eliminating the likelihood that the surgeon may need to perform a second fully-invasive craniotomy.
NIBIB http://tinyurl.com/gu285fb
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:40Imaging technique measures tumour stiffness to aid surgical planning
New research confirms that an innovative procedure combining MRI and ultrasound to create a 3D image of the prostate can more accurately locate suspicious areas and help diagnose whether it’s prostate cancer. Using specialized equipment needed, physicians at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center began using the fusion biopsy procedure about three years ago for its ability to blend live ultrasound images with captured MRI images. The fused image creates the 3D model, and flags anomalies that could be areas of concern. That helps guide urologists to get tissue samples called biopsies to determine whether cancer is present. UT Southwestern’s early adoption of the cutting-edge technology allowed researchers to report on the superior diagnostic performance of this novel approach compared to traditional methods for diagnosing prostate cancer. Furthermore, these researchers have partnered with colleagues in Brazil to conduct follow up studies that now show the technique consistently improved detection of clinically significant prostate cancer under a wide variety of conditions, even when radiologists were using different equipment and protocols. ‘In the past, we diagnosed prostate cancer by random biopsies of the prostate in men with elevated PSA values. With fusion biopsy, we actually find more cancer, we can differentiate between dangerous tumours and less aggressive tumours, and in some cases we perform fewer biopsies,’ said Dr. Daniel Costa, Assistant Professor of Radiology and with the Advanced Imaging Research Center (AIRC) at UT Southwestern. Prostate cancer is the second most common cancer diagnosed in men, after skin cancer. Prostate cancer risk increases with age, with most cases occurring after age 60. According to the National Cancer Institute (NCI), about 180,890 men will be diagnosed this year, and about 14 percent of men will be diagnosed sometime during their lifetime. The procedure, technically known as MRI-TRUS (magnetic resonance imaging/transrectal ultrasound) fusion targeted prostate biopsy, requires special imaging capabilities and high level training for both radiologists and urologists, so its use has not become widespread. It works like this: after the urologist identifies a patient at risk for prostate cancer, radiologists use a state-of-the-art MRI examination to identify potentially suspicious areas. If present, the MRI images are then sent to a device that blends those with an ultrasound used by urologists to take a biopsy or sample of the tissue in question to determine whether it has cancer. ‘In many instances, MRI-TRUS biopsies performed at UT Southwestern have allowed us to diagnose and treat aggressive prostate cancer in patients whose prior biopsies failed to find the cancer,’ said Dr. Ivan Pedrosa, Chief of the Division of Magnetic Resonance Imaging, Associate Professor of Radiology and with the Advanced Imaging Research Center, who holds the Jack Reynolds, M.D. Chair in Radiology. ‘Because of its improved precision, patients and physicians are better informed to choose the most appropriate treatment. This helps to avoid surgery in patients with less aggressive disease, and ensures that patients with more aggressive cancers are identified earlier.’
UT Southwestern Medical Center http://tinyurl.com/jotdkmc
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:40Fusion targeted prostate biopsy proves more accurate in diagnosis of prostate cancer
A multidisciplinary research team led by University of Houston scientist Jarek Wosik has developed a high-temperature superconducting coil that allows magnetic resonance imaging (MRI) scanners to produce higher resolution images or acquire images in a shorter time than when using conventional coils. Wosik, a principal investigator at the Texas Center for Superconductivity at UH, said test results show the new technology can reveal brain structures that aren’t easily visualized with conventional MRI coils. He also is a research professor in the UH Department of Electrical and Computer Engineering. The cryo-coil works by boosting the signal-to-noise ratio (SNR) – a measure of the strength of signals carrying useful information – by a factor of two to three, compared with conventional coils. SNR is critical to the successful implementation of high resolution and fast imaging. Wosik said the cryo-coil reveals more details than a conventional coil because of its enhanced SNR profile. Where a conventional coil does not have enough sensitivity to ‘see,’ a superconducting coil can still reveal details. These details will remain hidden to conventional coils even when image acquisition is repeated endlessly. For the initial tests, the probe was optimized for rat brain imaging, useful for biomedical research involving neurological disorders. But it also has direct implications for human healthcare, Wosik said. ‘Research in animal models yields critical information to improve diagnosis and treatment of human diseases and disorders,’ he said. ‘This work also has the potential to clearly benefit clinical MRI, both through high quality imaging and through shortening the time patients are in the scanner.’ Results from preliminary testing of the 7 Tesla MRI Cryo-probe were presented at the 2016 International Symposium of Magnetic Resonance in Medicine annual meeting last May. The coil can be optimized for experiments on living animals or brain tissue samples, and researchers said they demonstrated an isotropic resolution of 34 micron in rat brain imaging. In addition to its use in MRI coils, superconductivity lies at the heart of MRI scanning systems, as most high-field magnets are based on superconducting wire. Compared to corresponding standard room temperature MRI coils, the performance of the cooled normal metal and/or the high-temperature superconducting receiver coils lead either to an increase in imaging resolution and its quality, or to a very significant reduction in total scan time,’ Wosik said.
New scanning technology which will give a much clearer picture of lung disease has taken a major step forward thanks to scientists at The University of Nottingham. The experts at the Sir Peter Mansfield Imaging Centre have developed a process using specially treated krypton gas as an inhalable contrast agent to make the spaces inside the lungs show up on an Magnetic resonance imaging (MRI) scan. It’s hoped the new process will eventually allow doctors to virtually see inside the lungs of patients. Traditional magnetic resonance imaging uses hydrogen protons in the body as molecular targets to give a picture of tissue but this does not give a detailed picture of the lungs because they are full of air. Recent technological developments have led to a novel imaging methodology called Inhaled Hyperpolarized Gas MRI that uses lasers to hyperpolarize’ a noble (inert) gas which aligns (polarizes) the nuclei of the gas so it shows up on an MRI scan. The work will make 3D imaging using atomic spies’ like helium, xenon, or krypton possible in a single breath hold by the patient. Nottingham has pioneered hyperpolarized krypton MRI and is currently advancing this technology towards the clinical approval processes. Hyperpolarized MRI research has been trying to overcome a problem with these noble gases retaining their hyperpolarized state for long enough for the gas to be inhaled, held in the lungs and scanned. Now the Nottingham team has developed a new technique to generate hyperpolarized krypton gas at high purity, a step that will significantly facilitate the use of this new contrast agent for pulmonary MRI. Chair in Translational Imaging at the Sir Peter Mansfield Imaging Centre, Professor Thomas Meersmann, said: "It is particularly demanding to retain the hyperpolarized state of krypton during preparation of this contrast agent. We have solved a problem by using a process that is usually associated with clean energy related sciences. It’s called catalytic hydrogen combustion. To hyperpolarize the krypton-83 gas we diluted it in molecular hydrogen gas for the laser pumping process. After successful laser treatment the hydrogen gas is mixed with molecular oxygen and literally exploded it away in a safe and controlled fashion through a catalysed combustion reaction. "Remarkably, the hyperpolarized state of krypton-83 survives’ the combustion event. Water vapour, the sole product of the clean’ hydrogen reaction, is easily removed through condensation, leaving behind the purified laser-polarized krypton-83 gas diluted only by small remaining quantities of harmless water vapour. This development significantly improves the potential usefulness of laser-pumped krypton-83 as MRI contrast agent for clinical applications." This new technique can also be used to hyperpolarize another useful noble gas, xenon-129, and may lead to a cheaper and easier production of this contrast agent.
The University of Nottingham http://tinyurl.com/gwcp75m
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:37:362020-08-26 14:37:39Major breakthrough in new MRI scan technology for lung disease
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.